Is Brigatinib/Brigatinib covered by medical insurance?

Brigatinib/Brigatinib The original drug has been approved for marketing by the National Medical Products Administration and is sold under the name of brigatinib tablets. Its trade name is ALUNBRIG/ALUNBRIG. It has also entered the scope of Class B medical insurance through the regulations of the National Medical Insurance Administration, but only patients who meet the indications can be reimbursed, that is, patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC).SpecificationsThe price of each box of 30mg*14 tablets*2 tablets may be around RMB 8,000. Patients who do not meet the conditions can only purchase it at their own expense. The reimbursement ratio is different in different regions, and the price after reimbursement may be different.